|Bid||6.48 x 1000|
|Ask||6.49 x 900|
|Day's range||6.39 - 6.60|
|52-week range||5.31 - 22.69|
|Beta (5Y monthly)||1.58|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Growth stocks have lost momentum in August after a strong start to the year. Innovative companies in the fields of drug development and medical imaging, such as Agenus (NASDAQ: AGEN), BioCryst Pharmaceuticals (NASDAQ: BCRX), and Nano-X Imaging (NASDAQ: NNOX) have all experienced a significant drop in their stock prices in the past 30 days.
Nano-X Imaging ( NASDAQ:NNOX ) Second Quarter 2023 Results Key Financial Results Net loss: US$17.4m (loss narrowed by...
Earlier today, Nano-X Imaging Limited released financial results for the quarter ended June 30, 2023. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call.